am-404 and Respiratory-Insufficiency

am-404 has been researched along with Respiratory-Insufficiency* in 1 studies

Other Studies

1 other study(ies) available for am-404 and Respiratory-Insufficiency

ArticleYear
CB1 receptor-mediated respiratory depression by endocannabinoids.
    Respiratory physiology & neurobiology, 2017, Volume: 240

    Endocannabinoids (ECs) are bioactive lipid mediators acting on two distinct cannabinoid receptors (CB1 and CB2), which are ubiquitously expressed in many tissues including the respiratory system. Despite numerous experimental data showing that cannabinomimetics influence respiration, the role of endogenously produced ECs in respiratory control has not been verified yet. Pulse oximetry was used in the present study to directly measure changes in respiratory parameters during elevation of EC levels. The cannabinoid reuptake inhibitor AM-404 (10mgkg

    Topics: Animals; Arachidonic Acids; Endocannabinoids; Heart Rate; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Oximetry; Oxygen Consumption; Receptor, Cannabinoid, CB1; Respiration; Respiratory Insufficiency; Time Factors

2017